Mutation in the EGFR gene is less common, making targeted therapies using receptor tyrosine kinases inhibitors (TKRIs) less likely to be effective in treating ESCC (PMID: 23426935). The gene discussed is NTRK1; the disease is esophageal squamous cell carcinoma.